A study has found that the medications Pradaxa and Warfarin have similar bleeding rates after surgery takes place. The American Heart Association published the study in its journal, Circulation, and the information took into account the RE-LY study the FDA used to approve the medication... Read More

In the United States in 2011, there were 2,367 reports of Pradaxa hemorrhage, as well as 542 reports of Pradaxa deaths. The manufacturer Boehringer Ingelheim first introduced the anticoagulant drug on the market in 2010 as a superior alternative to Coumadin (also known as warfarin).... Read More

An Illinois resident filed a lawsuit regarding side effects of the clot-busting drug Pradaxa in the United States' District Court for the Southern District of Illinois recently. Jacqueline Boston filed her lawsuit on May 11, 2012, claiming that drug maker Boehringer Ingelheim Pharmaceuticals is liable... Read More

The family of a patient who had been prescribed Predaxa and died chose to file a Pradaxa lawsuit. According to the lawsuit, the victim died of internal bleeding. The bleeding was uncontrollable in the brain after taking the blood thinning drug. The case was filed... Read More

Pradaxa is an anticoagulant that has been recognized by many experts as one of the most dangerous pharmaceuticals in widespread use since it was approved by the Food and Drug Administration in 2010. The medication is among a new generation of blood thinners that can... Read More

Two new studies that attempted to evaluate whether the risk of bleeding from Pradaxa is greater than that of Warfarin came up with conflicting results. Study of surgical patients finds similar bleeding risk for both anticoagulants A study that used information from the Re-LY clinical... Read More

A Louisiana resident is claiming that Pradaxa drug maker Boehringer Ingelheim Pharmaceuticals, Inc. should be held liable for the side effects he experienced after taking the blood thinning medication. Arnold R. Sykes filed his lawsuit on the 18th of June, 2012, in the United States'... Read More

Pradaxa, an anticoagulant drug, is marketed as an effective competitor to Coumadin (warfarin). However, the drug has been linked to serious and potentially deadly side effects, including excessive bleeding resulting from Pradaxa. In the most severe and tragic of cases, families have reported death from... Read More